4//SEC Filing
REPLIGEN CORP 4
Accession 0001209191-15-020049
$RGENCIK 0000730272operating
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 8:29 AM ET
Size
7.5 KB
Accession
0001209191-15-020049
Insider Transaction Report
Form 4
REPLIGEN CORPRGEN
RUSCHE JAMES R
Senior Vice President
Transactions
- Award
Stock Option (Right to Buy)
2015-02-26+10,067→ 10,067 totalExercise: $24.98Exp: 2025-02-26→ Common Stock (10,067 underlying) - Award
Common Stock
2015-02-26+5,229→ 126,499 total
Footnotes (2)
- [F1]Mr. Rusche was awarded 5,229 Restricted Stock Units. Each Restricted Stock Unit represents a contingent right to receive one share of Repligen Corporation's Common Stock. The Restricted Stock Units vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date. The Restricted Stock Units may be settled only by delivering shares of Repligen Corporation's Common Stock, and thus, the grant is being reported in Table 1 as allowed per SEC guidance.
- [F2]The shares vest in equal annual installments over a three-year period beginning on the first anniversary of the grant date.
Documents
Issuer
REPLIGEN CORP
CIK 0000730272
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000730272
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 8:29 AM ET
- Size
- 7.5 KB